AMALGAMATED BANK - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.

Quarter-by-quarter ownership
AMALGAMATED BANK ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$1,427,000
+6.6%
9,437
+2.7%
0.01%
+16.7%
Q2 2022$1,339,000
+35.5%
9,192
+10.4%
0.01%
+50.0%
Q1 2022$988,000
-60.0%
8,329
-53.5%
0.01%
-11.1%
Q4 2021$2,468,000
+96.5%
17,906
+98.1%
0.01%
-18.2%
Q3 2021$1,256,000
+38.5%
9,041
-3.3%
0.01%
+57.1%
Q2 2021$907,000
+93.8%
9,347
+36.5%
0.01%
-61.1%
Q1 2021$468,000
-27.3%
6,850
-8.9%
0.02%
-25.0%
Q4 2020$644,000
+32.5%
7,518
+0.5%
0.02%
+14.3%
Q3 2020$486,000
-12.0%
7,478
-0.9%
0.02%
-19.2%
Q2 2020$552,000
+119.9%
7,549
+2.5%
0.03%
+333.3%
Q1 2020$251,000
-35.6%
7,367
+2.8%
0.01%
-14.3%
Q4 2019$390,000
+42.9%
7,169
+9.4%
0.01%
+16.7%
Q3 2019$273,000
+4.6%
6,554
+9.9%
0.01%0.0%
Q2 2019$261,000
+7.4%
5,966
+26.6%
0.01%0.0%
Q1 2019$243,0004,7140.01%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q4 2020
NameSharesValueWeighting ↓
RP Management, LLC 1,111,111$107,867,00052.60%
Knoll Capital Management, LLC 856,844$83,182,00043.44%
ORACLE INVESTMENT MANAGEMENT INC 2,082,555$202,174,00027.86%
ARS Investment Partners, LLC 558,286$54,198,0005.52%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 176,400$17,113,0004.52%
KINGDON CAPITAL MANAGEMENT, L.L.C. 401,006$38,930,0004.51%
Eventide Asset Management 1,990,797$193,267,0002.60%
SILVERARC CAPITAL MANAGEMENT, LLC 56,626$5,497,0002.45%
Avidity Partners Management LP 882,500$85,673,0002.32%
Nicholas Investment Partners, LP 363,708$35,309,0002.22%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders